1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pediatric Cancer Global Clinical Trials Review, H1, 2015

Pediatric Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2015" provides data on the Pediatric Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediatric Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pediatric Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pediatric Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pediatric Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Pediatric Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Pediatric Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Pediatric Cancer 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Pediatric Cancer Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Zaklad Farmaceutyczny Adamed Pharma S.A. 32
Clinical Trial Overview of Zaklad Farmaceutyczny Adamed Pharma S.A. 32
Stemline Therapeutics, Inc. 33
Clinical Trial Overview of Stemline Therapeutics, Inc. 33
Sanofi 34
Clinical Trial Overview of Sanofi 34
OncoTherapy Science, Inc. 35
Clinical Trial Overview of OncoTherapy Science, Inc. 35
Grindeks 36
Clinical Trial Overview of Grindeks 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Activartis Biotech GmbH 40
Clinical Trial Overview of Activartis Biotech GmbH 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
University of Texas M. D. Anderson Cancer Center 42
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 42
Duke University 43
Clinical Trial Overview of Duke University 43
The University of Hong Kong 44
Clinical Trial Overview of The University of Hong Kong 44
Erasmus MC 45
Clinical Trial Overview of Erasmus MC 45
The University of Queensland 46
Clinical Trial Overview of The University of Queensland 46
University of Kentucky 47
Clinical Trial Overview of University of Kentucky 47
Karolinska Institute 48
Clinical Trial Overview of Karolinska Institute 48
Chinese University of Hong Kong 49
Clinical Trial Overview of Chinese University of Hong Kong 49
Five Key Clinical Profiles 50
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

List of Tables
Pediatric Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Pediatric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pediatric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Pediatric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Pediatric Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Pediatric Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Pediatric Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Pediatric Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Pediatric Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Pediatric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Pediatric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Pediatric Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Pediatric Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Pediatric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Pediatric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Pediatric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Pediatric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Pediatric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zaklad Farmaceutyczny Adamed Pharma S.A., 2015* 32
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemline Therapeutics, Inc., 2015* 33
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 34
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OncoTherapy Science, Inc., 2015* 35
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Grindeks, 2015* 36
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 38
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Activartis Biotech GmbH, 2015* 40
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 41
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 42
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 43
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2015* 44
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 45
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Queensland, 2015* 46
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 47
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2015* 48
Pediatric Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 49

List of Figures
Pediatric Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Pediatric Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pediatric Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Pediatric Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Pediatric Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Pediatric Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Pediatric Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Pediatric Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Pediatric Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Pediatric Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Pediatric Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Pediatric Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Pediatric Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Pediatric Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Pediatric Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Pediatric Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Pediatric Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Pediatric Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.